Our objective is the development of a detailed model for the activation of globin gene expression in murine erythroleukemia (MEL) cells. The specific goal is to identify and characterize nuclear proteins from MEL cells which directly interact with cloned globin gene DNA fragments. A rapid and unambiguous binding assay will be used to identify factors capable of forming stable complexes with Alpha- and Beta-globin gene promoter regions. The binding assay will be used to evaluate enrichment of specific binding activities by conventional chromatography. Using this approach we show in preliminary results that a protein which binds to the CCAAT-box of the Alpha-globin gene has been extensively enriched. We propose use the binding assay to identify additional factors that interact with the globin genes. DNA sequences required for factor binding will be determined by DNase I footprinting. Binding sites will be extensively characterized by producing a series of deletion and point mutations in order to identify minimal binding sites. Minimal binding sites will be transferred into non-binding domains to confirm the identity of the binding site. Protein factors responsible for binding activity will be determined by extensive chromatographic protocols and by isolating proteins-nucleic acid complexes and determining their protein content. We will use in vitro transcription assays to determine if fractionated nuclear extracts can be reconstituted, stimulated or repressed by the factors we will enrich. To determine if binding sites indentified in vitro are occupied within the nucleus, in vivo footprinting experiments will be performed. The isolation and characterization of proteins that bind directly to the globin genes will provide novel insights into the regulation of these genes. It is of interest to note that a naturally occurring mutation in the CCAAT box of a human fetal globin gene has recently been implicated in the inappropriate expression of this gene during adult life. Identification of proteins that bind to these regions in vitro might provide insights into how these mutations enhance fetal globin gene expression, and could significantly advance our understanding of these inherited hematologic disorders. It is also not unreasonable to speculate that the expression of cellular onc-genes might be regulated by specific protein-nucleic acid interactions. A general understanding of these interactions could thus lead to significant increases in our understanding of the regulation of cell growth.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK037513-01
Application #
3236478
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1986-08-01
Project End
1989-07-31
Budget Start
1986-08-01
Budget End
1987-07-31
Support Year
1
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Swendeman, S L; Spielholz, C; Jenkins, N A et al. (1994) Characterization of the genomic structure, chromosomal location, promoter, and development expression of the alpha-globin transcription factor CP2. J Biol Chem 269:11663-71
Zhong, F; Swendeman, S L; Popik, W et al. (1994) Evidence that levels of the dimeric cellular transcription factor CP2 play little role in the activation of the HIV-1 long terminal repeat in vivo or following superinfection with herpes simplex virus type 1. J Biol Chem 269:21269-76
Lim, L C; Fang, L; Swendeman, S L et al. (1993) Characterization of the molecularly cloned murine alpha-globin transcription factor CP2. J Biol Chem 268:18008-17
Lim, L C; Swendeman, S L; Sheffery, M (1992) Molecular cloning of the alpha-globin transcription factor CP2. Mol Cell Biol 12:828-35
Kim, C G; Swendeman, S L; Barnhart, K M et al. (1990) Promoter elements and erythroid cell nuclear factors that regulate alpha-globin gene transcription in vitro. Mol Cell Biol 10:5958-66
Kim, C G; Sheffery, M (1990) Physical characterization of the purified CCAAT transcription factor, alpha-CP1. J Biol Chem 265:13362-9
Barnhart, K M; Kim, C G; Sheffery, M (1989) Purification and characterization of an erythroid cell-specific factor that binds the murine alpha- and beta-globin genes. Mol Cell Biol 9:2606-14
Sheffery, M; Kim, C G; Barnhart, K M (1989) Purification of four erythroid cell proteins that bind the promoters of the murine globin genes. Prog Clin Biol Res 316A:343-57
Barnhart, K M; Kim, C G; Banerji, S S et al. (1988) Identification and characterization of multiple erythroid cell proteins that interact with the promoter of the murine alpha-globin gene. Mol Cell Biol 8:3215-26
Kim, C G; Barnhart, K M; Sheffery, M (1988) Purification of multiple erythroid cell proteins that bind the promoter of the alpha-globin gene. Mol Cell Biol 8:4270-81